Plain-English translation of NCT07442539 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing liposomal bupivacaine, a newer pain-relief medication that works for up to 72 hours, to see if it reduces pain better than standard pain medication after hemorrhoid surgery. Right now, regular pain medication only works for a few hours, so patients often have significant pain after going home. Researchers want to know if this longer-lasting medication is both safe and more effective for this type of surgery.
Hemorrhoid surgery is known for causing severe pain afterward, and that pain often makes people put off getting the surgery they need. Doctors are looking for better pain-control options that last longer and require fewer injections, so patients recover more comfortably and are willing to get treatment when they need it.
You likely qualify if…
You likely don't qualify if…
If you join, you will undergo hemorrhoid surgery as planned, but during the procedure, you'll receive either standard pain medication or the new longer-acting pain medication injected into the surgical area. After surgery, you'll be monitored and asked to report your pain levels at regular intervals. The study team will track how well the medication works, how long it lasts, and whether you experience any side effects over the first few days of recovery.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
China